217 related articles for article (PubMed ID: 11594010)
1. [HTLV-I/II seroprevalence and risk factors associated with infection in a blood donor population in Córdoba, Argentina].
Gallego S; Maturano E; Recalde A; Gastaldello R; Sileoni S; Bepre H; Medeot S
Rev Argent Microbiol; 2001; 33(3):182-6. PubMed ID: 11594010
[TBL] [Abstract][Full Text] [Related]
2. [Absence of HTLV-I/II virus circulation in blood donors from the provinces of Santa Fe and Santiago del Estero].
Gastaldello R; Fazzola P; Caeiro L; Maturano E; Perez De Rosas A; Fernandez I; Racca R; Rodriguez MB; Molina M; Alonso S; Gallego S
Rev Argent Microbiol; 2002; 34(2):107-9. PubMed ID: 12180256
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of commercial equipment used in blood banks in Córdoba for the detection of anti-HTLV-I/II antibodies].
Llop N; Gastaldello R; Valle M; Macedo R; Maturano E; Blanco S; Medeot S; Gallego S
Rev Argent Microbiol; 2000; 32(4):202-5. PubMed ID: 11149153
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of HTLV-I/II in blood donors in Monterrey, Mexico.
Trejo-Avila LM; Fuentes-Pensamiento R; Scorro Flores-Castañeda M; Diaz-Mendoza ML; Zapata-Benavides P; Tamez-Guerra RS
Arch Med Res; 1996; 27(1):97-9. PubMed ID: 8867376
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of HTLV-I and HTLV-II among blood donors in Argentina: a South American health concern.
Biglione MM; Astarloa L; Salomón HE;
AIDS Res Hum Retroviruses; 2005 Jan; 21(1):1-4. PubMed ID: 15665638
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
[TBL] [Abstract][Full Text] [Related]
7. HTLV-I/II infections in Spain. The HTLV-I/II Spanish Study Group.
Soriano V; Calderón E; Esparza B; Cilla G; Aguilera A; Gutiérrez M; Tor J; Pujol E; Merino F; Pérez-Trallero E
Int J Epidemiol; 1993 Aug; 22(4):716-9. PubMed ID: 8225748
[TBL] [Abstract][Full Text] [Related]
8. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
Mangano AM; Remesar M; del Pozo A; Sen L
J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of Human T-Cell Lymphotropic Virus-1/2 in Blood Donors in Northern Pakistan: Implications for Blood Donor Screening.
Niazi SK; Bhatti FA; Salamat N
J Coll Physicians Surg Pak; 2015 Dec; 25(12):874-7. PubMed ID: 26691361
[TBL] [Abstract][Full Text] [Related]
10. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
Blejer JL; Saguier MC; Salamone HJ; Carreras LA
Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
[TBL] [Abstract][Full Text] [Related]
11. [Prevalence of HTLV-I and HTLV-II infection in Puglia].
Quarto M; Chironna M; Germinario C; Lopalco PL; Barbuti S
Ann Ig; 1996; 8(6):649-55. PubMed ID: 9312232
[No Abstract] [Full Text] [Related]
12. Human T-cell lymphotropic virus type I and II seroprevalence among volunteer blood donors in Thailand.
Oota S; Chaiwong K; Pikulsod S; Khuenkaew R; Pheakkhuntod S; Rattajak P; Kramkratok P; Shiu C; Bhatnagar S; Sakuldamrongpanich T
Pathog Glob Health; 2018 Oct; 112(7):343-348. PubMed ID: 30424716
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of HTLV-1/2 Among Voluntary Blood Donors in Vietnam.
Pham D; Nguyen D; Nguyen TA; Tran C; Tran L; Devare S; Tran A; Bhatnagar S
AIDS Res Hum Retroviruses; 2019 Apr; 35(4):376-381. PubMed ID: 30565470
[TBL] [Abstract][Full Text] [Related]
14. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia.
Fawaz NA; Tamim H; Almawi WY
Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675
[TBL] [Abstract][Full Text] [Related]
15. A seroepidemiological survey of HTLV-I/II carriers in the Puna Jujeña.
Dipierri JE; Tajima K; Cartier Robirosa L; Sonoda S
Medicina (B Aires); 1999; 59(6):717-20. PubMed ID: 10752214
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
Kwon SY; Lim AH; Park JY; Han SH; Cho NS
J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809
[TBL] [Abstract][Full Text] [Related]
17. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
Kumar H; Gupta PK
Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
[TBL] [Abstract][Full Text] [Related]
18. HTLV type I and HTLV type II infection among Indians and natives from Argentina.
Bouzas MB; Zapiola I; Quiruelas S; Gorvein D; Panzita A; Rey J; Carnese FP; Corral R; Perez C; Zala C
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1567-71. PubMed ID: 7888211
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection. Women's Interagency HIV Study.
Telzak EE; Hershow R; Kalish LA; Hardy WD; Zuckerman E; Levine A; Delapenha R; DeHovitz J; Greenblatt RM; Anastos K
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):513-8. PubMed ID: 9859966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
